Farther Finance Advisors’s Usana Health Sciences USNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$41.9K Buy
1,964
+1,647
+520% +$31K ﹤0.01% 3386
2026
Q1
$5.46K Sell
317
-528
-62% -$10.5K ﹤0.01% 4445
2025
Q4
$16.6K Buy
845
+306
+57% +$6.35K ﹤0.01% 3561
2025
Q3
$14.8K Sell
539
-198
-27% -$6.09K ﹤0.01% 3223
2025
Q2
$22.5K Buy
737
+263
+55% +$7.47K ﹤0.01% 2604
2025
Q1
$12.9K Buy
474
+76
+19% +$2.41K ﹤0.01% 2609
2024
Q4
$14.3K Hold
398
﹤0.01% 2222
2024
Q3
$15.1K Buy
398
+388
+3,880% +$15.9K ﹤0.01% 2198
2024
Q2
$448 Sell
10
-9
-47% -$414 ﹤0.01% 3307
2024
Q1
$911 Buy
19
+9
+90% +$441 ﹤0.01% 2811
2023
Q4
$536 Sell
10
-12
-55% -$607 ﹤0.01% 2954
2023
Q3
$1.29K Hold
22
﹤0.01% 2003
2023
Q2
$1.39K Hold
22
﹤0.01% 1876
2023
Q1
$1.38K Hold
22
﹤0.01% 1760
2022
Q4
$1.17K Buy
+22
New +$1.19K ﹤0.01% 1610

Other funds holding USNA

Farther Finance Advisors's USNA Position: Q2 2026 in Review

Farther Finance Advisors increased its Usana Health Sciences (USNA) stake by 520% in Q2 2026, buying an estimated $31K and bringing the position to 1,964 shares worth $41.9K. The position accounts for ﹤0.01% of the portfolio, ranked #3386.

Farther Finance Advisors first reported a position in USNA in Q4 2022 and has held it in 15 quarters since. 13 funds tracked by Wall St. Rank hold USNA as of Q2 2026.

  • Farther Finance Advisors held 1,964 shares of Usana Health Sciences worth $41.9K as of Q2 2026.
  • Farther Finance Advisors bought 1,647 Usana Health Sciences shares in Q2 2026, an estimated $31K.
  • Usana Health Sciences made up ﹤0.01% of Farther Finance Advisors's portfolio in Q2 2026, its #3386 holding.
  • Farther Finance Advisors first reported a position in Usana Health Sciences in Q4 2022 and has held it in 15 quarters since.
  • 13 funds tracked by Wall St. Rank held Usana Health Sciences as of Q2 2026.

Based on Farther Finance Advisors's 13F filing for Q2 2026, filed 17 Jul 2026.